VNDA Vanda Pharmaceuticals Inc.

bullish track record → $6.99 -0.28 (-3.9%)
Get emailed when VNDA changes direction
Mkt Cap $413M 52wk $3.81 - $9.94 Earnings 2026-05-06 47d ago
Insider selling: $2,896,087 sold by 10 insiders (30d)
Est. revisions: -0.3%
Backed by structured data (insider trades, analyst ratings, or filings)
Factor Model (net -1.4)

Factor Model

net -1.4 3.8 / 10
Est. Revisions
-0.0
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0

FDA approves Bysanti tablets, stock surges 34%

Watch: Watch Q2 and Q3 prescriptions and revenue guidance for Bysanti. That will tell you whether this approval translates to a durable business driver or becomes a one-time pop that fades as market expectations reset.

Vanda Pharmaceuticals got FDA approval for Bysanti tablets on Monday, sending shares up 34.37% in premarket trading. The approval marks a regulatory win and near-term validation of the company's pipeline. Vanda's stock is showing strength across near-term, medium-term, and longer-term momentum indicators.

This is a binary catalyst event — hard regulatory approval that de-risks a key product and opens a new revenue stream. The market's immediate 34% pop reflects the approval's significance, but the real test is execution: whether Bysanti gains market adoption and drives sustained revenue growth for a biotech that's historically been execution-dependent.

Evidence

8d ago Insider buy by MORAN KEVIN PATRICK (VNDA): $8,779
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $44,640
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $47,650
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $47,600
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $47,050
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $50,200
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $50,150
8d ago Insider buy by POLYMEROPOULOS MIHAEL HRISTOS (VNDA): $84,472
5 older signals
Fundamentals & Data ▾
Vanda Pharmaceuticals Inc. Healthcare · Biotechnology
Mkt Cap
$413M
Beta
0.71
52w Range
$3.81 - $9.94
Short Interest
5.3M 9.32%
Days to Cover
2.7 +22%
Technicals downtrend
from 52w Hi
-6.2%
1w return
-2.4%
Insiders
selling 3B / 7S
EPS Estimate
$-0.69 -0.3% 30d 0up / 3dn
Est. Dispersion
65% 5 analysts
Analyst Target
$16 $8 - $24
Options P/C
0.02
Insider Cluster
strong buy 2B / 7S (officer)
Fund Convergence
strong Renaissance, Two Sigma, D.E. Shaw, Citadel
Financials
Revenue
$57M +8% YoY
FCF
$-30M
Gross Margin
93%
Op Margin
-70%
Momentum: decelerating
Top Holders
Renaissance $30M
Two Sigma $9M
D.E. Shaw $2M
Citadel $2M
Recent Filings & Data
insider trade 35
net selling · $2,896,087 sold · $466,036 bought
10 insiders · 35 transactions (30d)
Recent transactions
POLYMEROPOULOS MIHAEL HRISTOS · sell · $1,276,971
BIRZNIEKS GUNTHER · sell · $350,730
WILLIAMS TIMOTHY IAN · sell · $350,755
WIJKSTROM JOAKIM PER · sell · $254,590
MORAN KEVIN PATRICK · sell · $350,821
HONORE TAGE · sell · $240,900
POLYMEROPOULOS MIHAEL HRISTOS · award
BIRZNIEKS GUNTHER · award
WILLIAMS TIMOTHY IAN · award
WIJKSTROM JOAKIM PER · award
MORAN KEVIN PATRICK · award
POLYMEROPOULOS MIHAEL HRISTOS · buy · $41,500
MITCHELL STEPHEN RAY · sell · $32,130
DUGAN RICHARD W · award
CHROUSOS PHAEDRA · award
WARD ANNE SEMPOWSKI · award
MITCHELL STEPHEN RAY · award
HONORE TAGE · award
POLYMEROPOULOS MIHAEL HRISTOS · buy · $43,995
POLYMEROPOULOS MIHAEL HRISTOS · buy · $84,472
POLYMEROPOULOS MIHAEL HRISTOS · buy · $50,150
POLYMEROPOULOS MIHAEL HRISTOS · buy · $50,200
POLYMEROPOULOS MIHAEL HRISTOS · buy · $47,050
POLYMEROPOULOS MIHAEL HRISTOS · buy · $47,600
POLYMEROPOULOS MIHAEL HRISTOS · buy · $47,650
POLYMEROPOULOS MIHAEL HRISTOS · buy · $44,640
MORAN KEVIN PATRICK · buy · $8,779
POLYMEROPOULOS MIHAEL HRISTOS · award
MITCHELL STEPHEN RAY · sell · $25,863
MORAN KEVIN PATRICK · sell · $13,327
CHROUSOS PHAEDRA · award
DUGAN RICHARD W · award
WARD ANNE SEMPOWSKI · award
MITCHELL STEPHEN RAY · award
HONORE TAGE · award
13 signals · latest 8d ago

Get alerted when VNDA changes direction

We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.